Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Russo

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|March 19, 2019
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk PatientsMichael J Mack, Martin B Leon, Vinod H Thourani, et al.
Journal of the American College of Cardiology|March 5, 2021
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical RiskMartin B Leon, Michael J Mack, Rebecca T Hahn, et al.
The Annals of Thoracic Surgery|February 5, 2024
Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement: Analysis of the PARTNER TrialsVinod H Thourani, Amr E Abbas, Julien Ternacle, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
JACC. Cardiovascular Imaging|April 17, 2025
5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsRebecca T Hahn, Julien Ternacle, Iria Silva, et al.
Lancet (London, England)|November 19, 2025
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption studyRaj R Makkar, Vinod H Thourani, Torsten P Vahl, et al.
Circulation|April 11, 2020
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 TrialPhilippe Pibarot, Erwan Salaun, Abdellaziz Dahou, et al.
The Annals of Thoracic Surgery|November 17, 2021
Association of Volume and Outcomes in 234 556 Patients Undergoing Surgical Aortic Valve ReplacementVinod H Thourani, James M Brennan, J James Edelman, et al.
JAMA Cardiology|June 24, 2026
Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical TrialJulien Ternacle, Rebecca T Hahn, Iria Silva, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|March 19, 2019
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk PatientsMichael J Mack, Martin B Leon, Vinod H Thourani, et al.
Journal of the American College of Cardiology|March 5, 2021
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical RiskMartin B Leon, Michael J Mack, Rebecca T Hahn, et al.
The Annals of Thoracic Surgery|February 5, 2024
Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement: Analysis of the PARTNER TrialsVinod H Thourani, Amr E Abbas, Julien Ternacle, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
JACC. Cardiovascular Imaging|April 17, 2025
5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsRebecca T Hahn, Julien Ternacle, Iria Silva, et al.
Lancet (London, England)|November 19, 2025
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption studyRaj R Makkar, Vinod H Thourani, Torsten P Vahl, et al.
Circulation|April 11, 2020
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 TrialPhilippe Pibarot, Erwan Salaun, Abdellaziz Dahou, et al.
The Annals of Thoracic Surgery|November 17, 2021
Association of Volume and Outcomes in 234 556 Patients Undergoing Surgical Aortic Valve ReplacementVinod H Thourani, James M Brennan, J James Edelman, et al.
JAMA Cardiology|June 24, 2026
Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical TrialJulien Ternacle, Rebecca T Hahn, Iria Silva, et al.
Pageof 8